Table 17 Normalized decision matrix of drugs and topological indices.

From: Multi criterion decision making analysis of hematologic cancer drugs via topological indices and physicochemical properties

Drugs

\(M_1\)

\(M_2\)

H

F

SS

ABC

RI

SC

GA

HZ

N

Bosutinib

0.7153

0.7423

0.7105

0.7095

0.7200

0.6948

0.7020

0.7085

0.7172

0.7249

0.7115

Carfilzomib

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

1.0000

1.000000

Cyclophosphamide

0.2461

0.2440

0.2726

0.2485

0.2493

0.2511

0.2709

0.2623

0.2551

0.2464

0.2491

cytarabine

0.3384

0.3559

0.3209

0.3502

0.3317

0.3256

0.3229

0.3233

0.3258

0.3529

0.3323

Daunorubicin

0.8307

0.9152

0.7113

0.9071

0.7921

0.7579

0.7206

0.7355

0.7585

0.9109

0.7595

Fludarabine

0.4230

0.4576

0.3825

0.4431

0.4124

0.3946

0.3836

0.3904

0.4005

0.4499

0.4109

Ibrutinib

0.6846

0.7220

0.6642

0.6766

0.6912

0.6555

0.6500

0.6679

0.6859

0.6979

0.6787

Lenalidomide

0.4000

0.4271

0.3657

0.4131

0.3926

0.3778

0.3656

0.3735

0.3831

0.4197

0.3906

Pomalidomide

0.4230

0.4576

0.3811

0.4431

0.4122

0.3963

0.3828

0.3900

0.4002

0.4499

0.4109

Thalidomide

0.4000

0.4305

0.3671

0.4131

0.3932

0.3768

0.3662

0.3740

0.3839

0.4213

0.3904

Zanubrutinib

0.7230

0.7627

0.6992

0.7185

0.7276

0.6928

0.6866

0.7035

0.7209

0.7392

0.7156

Back to article page